Results 71 to 80 of about 14,173 (257)
Evaluation of illicit drug contaminants in seized cannabis in Arizona and California, 2023–2024
Journal of Forensic Sciences, EarlyView.Abstract Despite public health concerns, fentanyl, cocaine, and other illicit drug contaminants remain largely understudied in unregulated cannabis. Here, we developed an analytical method to quantify a panel of common illicit drugs in cannabis and tested the law enforcement seizures in Arizona and California in evaluation of the illicit drug ...
Beckner Andersano +3 more
wiley +1 more source
The prevalence of cannabidiol (CBD) use in North America and Europe: A meta‐analysis
Addiction, EarlyView.Abstract Background and aims The global cannabidiol (CBD) market has expanded in recent years. Several studies suggest CBD use, whether for medical or recreational purposes, is on the rise; however, no systematic assessments of its prevalence have been conducted so far. This meta‐analysis aimed to estimate the prevalence of CBD use in North America and
Sara Weidberg +4 more
wiley +1 more source
Perspectives on drugs: Synthetic cannabinoids in Europe.
, 2015 Synthetic cannabinoids represent the largest group of compounds currently monitored in Europe by the EU Early warning system on new psychoactive substances. Current knowledge on these substances, as well as trends in production, availability and use, are
core
The Psychopharmacology of Novel Synthetic Cannabinoids [PDF]
, 2017 Over recent years, the rapid proliferation of novel psychoactive substances has presented significant challenges to health professionals, regulators, and forensic scientists alike.
Kevin, Richard Charles
core
Addiction, EarlyView.Abstract Background and aims Cannabis is the most widely used illicit drug worldwide and is often co‐used with tobacco, the leading cause of preventable death. Although cannabis and tobacco have distinct neurobiological actions, their associations with brain volumes are unclear.
Katherine Sawyer +16 more
wiley +1 more source
Novel psychoactive substances: synthetic cannabinoids - best practice treatment approaches.
, 2017 The use of new psychoactive substances [NPS] in prisons has been recognised as an increasing problem for several years. Successive Chief Inspectors of Prisons and the Prisons and Probation Ombudsman in the UK have drawn attention to the impact on prisons,
Ryan, George
core
Health Risk Behaviors With Synthetic Cannabinoids Versus Marijuana
, 2017 BACKGROUND AND OBJECTIVES: Data are limited on the behavioral risk correlates of synthetic cannabinoid use. The purpose of this study was to compare the behavioral risk correlates of synthetic cannabinoid use with ...
Heather B. Clayton +4 more
core +1 more source
Addiction, EarlyView.Abstract Background and aims Nitazenes are a novel subclass of synthetic opioids that have been increasingly implicated in the United States (US) overdose crisis. Despite their growing presence in the illicit drug supply, national trends have not been systematically evaluated.
David T. Zhu +3 more
wiley +1 more source
Bulletin of Kharkiv National University of Internal AffairsThe illegal circulation of synthetic cannabinoids intensifies criminal threats and negatively impacts vulnerable segments of the population due to their specific effects on the human psychophysiological state.
O. M. Serdega
doaj +1 more source
Vaping Synthetic Cannabinoids: A Novel Preclinical Model of E-Cigarette Use in Mice
Substance Abuse: Research and Treatment, 2017 Smoking is the most common route of administration for cannabis; however, vaping cannabis extracts and synthetic cannabinoids (“fake marijuana”) in electronic cigarette devices has become increasingly popular.
Timothy W Lefever +6 more
doaj +1 more source